ArticleJournal of Cancer2019

CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling.

Aichun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.